PHSE
Pharmhouse Corp
0.0127$
+32.3%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 15 | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q1 21 | Q2 21 | Q3 21 | Q2 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.4% | +17.9% | -34.1% | -6.4% | +0.0% | +0.0% | -36.3% | +0.0% | +0.0% | -0.1% | -68.2% | +0.0% | – | – | – | – | – | – | – | +2,150.0% | -46.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +86.3% | -3.2% | -11.7% | – | |
| – | -16.3% | -17.0% | +9.4% | +37.4% | +0.0% | +0.0% | -54.4% | +0.0% | +0.0% | -0.2% | -76.5% | +0.0% | -79.7% | +0.0% | +0.0% | -2.4% | – | – | – | -118.1% | – | +0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | +100.9% | +0.7% | -8.3% | – | |
| – | +2,564.0% | +176.7% | -93.4% | -1,002.5% | – | – | – | – | – | – | – | +0.0% | -159.0% | – | – | – | – | – | – | – | -68.5% | -100.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | +82.4% | -4.4% | -12.7% | – | |
| – | -86.5% | +366.7% | -85.7% | +875.0% | +0.0% | +0.0% | -85.8% | +0.0% | +0.0% | +0.5% | -26.6% | +0.0% | +169.6% | – | – | – | – | -63.4% | +5,768.3% | -96.1% | +733.9% | -0.4% | – | – | -90.6% | +1,135.4% | -99.4% | +10,808.4% | -24.9% | -90.1% | +519.8% | -89.2% | +912.3% | +459.1% | +148.7% | +625.9% | -59.3% | -35.9% | – | |
| – | – | -219.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,005.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -31.3% | +2.5% | +35.2% | -18.3% | +0.0% | +0.0% | -43.6% | +0.0% | +0.0% | +0.0% | -52.5% | +0.0% | +72.9% | -22.9% | -25.0% | +0.0% | +66.7% | – | – | – | +614.4% | +0.0% | – | – | +2.3% | +0.0% | -1.1% | +3,129.3% | -76.9% | +729.5% | -72.1% | +298.3% | -57.7% | +2,420.2% | -95.4% | -63.9% | -89.7% | +8,305.3% | – | |
| – | – | -822.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,246.7% | – | – | – | – | – | – | -153.8% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -822.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,246.7% | – | – | – | – | – | – | -153.8% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -219.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,235.5% | – | – | – | – | -14,450.9% | – | -135.2% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.